Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019032437) LIPOSOMAL TAXANES FOR TREATMENT OF SCLC
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/032437 International Application No.: PCT/US2018/045339
Publication Date: 14.02.2019 International Filing Date: 06.08.2018
IPC:
A61K 31/555 (2006.01) ,A61K 9/127 (2006.01) ,A61P 35/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
555
containing heavy metals, e.g. hemin, hematin, melarsoprol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
127
Liposomes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
CYTORI THERAPEUTICS, INC. [US/US]; 3020 Callan Road San Diego, California 92121, US
Inventors:
MARINO, Mark T.; US
Agent:
FURMAN, Eric S.; US
Priority Data:
62/542,99309.08.2017US
Title (EN) LIPOSOMAL TAXANES FOR TREATMENT OF SCLC
(FR) TAXANES LIPOSOMAUX POUR LE TRAITEMENT D'UN CPPC
Abstract:
(EN) Methods for therapy for a small cell lung cancer (SCLC), which may or may not respond to a first-line therapy or that progresses following cessation of a first-line chemotherapy is provided. Some methods include the administration of composition that comprises a protein-stabilized form of docetaxel, optionally in conjunction with a regimen of supportive care.
(FR) L'invention concerne des méthodes de traitement d'un cancer pulmonaire à petites cellules (CPPC), pouvant ou non répondre à une thérapie de première ligne ou progressant après l'arrêt d'une chimiothérapie de première ligne. Certains procédés comprennent l'administration d'une composition qui comprend une forme de docétaxel stabilisée par des protéines, éventuellement conjointement avec un régime de soins de soutien.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)